HBV infection decreases risk of liver metastasis in patients with colorectal cancer: A cohort study

World Journal of Gastroenterology

Volumn 17, Issue 6, 2011, Pages 804-808

  Qiu, Hai Bo ^a   Zhang, Li Yi ^a   Zeng, Zhao Lei ^a   Wang, Zhi Qiang ^a   Luo, Hui Yan ^a   Keshari, Rajiv Prasad ^a   Zhou, Zhi Wei ^a   Xu, Rui Hua ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Colorectal cancer; Hepatitis B virus; Liver metastasis; Risk

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN; FLUOROURACIL; FOLINIC ACID; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B ANTIBODY; HEPATITIS B ANTIGEN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LACTATE DEHYDROGENASE; OXALIPLATIN; TUMOR MARKER;

ABDOMINAL RADIOGRAPHY; ADOLESCENT; ADULT; AGED; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD EXAMINATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL EXAMINATION; COHORT ANALYSIS; COLORECTAL CANCER; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENDOSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRAHEPATIC METASTASIS; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS B; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER DYSFUNCTION; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; RISK REDUCTION; SEROLOGY; SURVIVAL RATE; TUMOR IMMUNITY;

EID: 79955929409     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i6.804     Document Type: Article

References (23)

1. Garcia M, Jemal A, Ward EM, Center MM, Hao Y, Siegel RL, Thun MJ, Global Cancer Facts & Figures 2007. Atlanta, GA: American Cancer Society, 2007: 1-50
2. Van Cutsem E, Nordlinger B, Adam R, Köhne CH, Pozzo C, Poston G, Ychou M, Rougier P. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer 2006; 42: 2212-2221
3. Alberts SR, Horvath WL, Sternfeld WC, Goldberg RM, Mahoney MR, Dakhil SR, Levitt R, Rowland K, Nair S, Sargent DJ, Donohue JH. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol 2005; 23: 9243-9249
4. Foster JH. Treatment of metastatic disease of the liver: a skeptic's view. Semin Liver Dis 1984; 4: 170-179
5. Sun Z, Ming L, Zhu X, Lu J. Prevention and control of hepatitis B in China. J Med Virol 2002; 67: 447-450
6. De Mitri MS, Cassini R, Bernardi M. Hepatitis B virus-related hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections. Eur J Cancer 2010; 46: 2178-2186
7. Wang J, Li Q, Sun Y, Zheng H, Cui Y, Li H, Zhou H, Hao X. Clinicopathologic features between multicentric occurrence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV. Surg Oncol 2009; 18: 25-30
8. Utsunomiya T, Saitsu H, Saku M, Yoshida K, Matsumata T, Shimada M, Sugimachi K. Rare occurrence of colorectal cancer metastasis in livers infected with hepatitis B or C virus. Am J Surg 1999; 177: 279-281
9. Song E, Chen J, Ou Q, Su F. Rare occurrence of metastatic colorectal cancers in livers with replicative hepatitis B infection. Am J Surg 2001; 181: 529-533
10. Okuno K, Hirai N, Lee YS, Kawai I, Shigeoka H, Yasutomi M. Involvement of liver-associated immunity in hepatic metastasis formation. J Surg Res 1998; 75: 148-152
11. Greece F, Fleming I, Fritz A. AJCC Cancer Staging Manual. New York: Springer-Verlag, 2002
12. Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J Jr, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C. NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw 2009; 7: 778-831
13. Desch CE, Benson AB 3rd, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Pfister DG, Virgo KS, Petrelli NJ. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005; 23: 8512-8519
14. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507-539
15. Hatanaka K, Kudo M, Fukunaga T, Ueshima K, Chung H, Minami Y, Sakaguchi Y, Hagiwara S, Orino A, Osaki Y. Clinical characteristics of NonBNonC- HCC: Comparison with HBV and HCV related HCC. Intervirology 2007; 50: 24-31
16. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Management of hepatitis B: summary of a clinical research workshop. Hepatology 2007; 45: 1056-1075
17. Kornprat P, Jarnagin WR, Gonen M, DeMatteo RP, Fong Y, Blumgart LH, D'Angelica M. Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol 2007; 14: 1151-1160
18. Portier G, Elias D, Bouche O, Rougier P, Bosset JF, Saric J, Belghiti J, Piedbois P, Guimbaud R, Nordlinger B, Bugat R, Lazorthes F, Bedenne L. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 2006; 24: 4976-4982
19. Doherty DG, Norris S, Madrigal-Estebas L, McEntee G, Traynor O, Hegarty JE, O'Farrelly C. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J Immunol 1999; 163: 2314-2321
20. McDonald B, Spicer J, Giannais B, Fallavollita L, Brodt P, Ferri LE. Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms. Int J Cancer 2009; 125: 1298-1305
21. Tordjmann T, Soulie A, Guettier C, Schmidt M, Berthou C, Beaugrand M, Sasportes M. Perforin and granzyme B lytic protein expression during chronic viral and autoimmune hepatitis. Liver 1998; 18: 391-397
22. Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, Kammula US, Chen Y, Qin LX, Tang ZY, Wang XW. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 2006; 10: 99-111
23. Mueller MM, Fusenig NE. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004; 4: 839-849